Data as of 1:30pm ET
| +0.05 / +0.78%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 9.83, with a high estimate of 9.83 and a low estimate of 9.83. The median estimate represents a +51.20% increase from the last price of 6.50.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.